A Comprehensive Analysis of COVID-19 Mortality Epidemiological and Demographic Variations Volume 57- Issue 4

Murad Ali Khan*

• Department of Computer Engineering, Jeju National University, Republic of Korea

Received: July 07, 2024; Published: July 19, 2024

*Corresponding author: Murad Ali Khan, Department of Computer Engineering, Jeju National University, Jeju 63243, Republic of Korea

DOI: 10.26717/BJSTR.2024.57.009039

Abstract PDF

The COVID-19 pandemic has had a profound impact on global health, revealing significant disparities in mortality rates across various demographic and epidemiological factors. This mini review aims to provide a comprehensive analysis of the key epidemiological findings, demographic variations, and geographical differences in COVID-19 mortality. Our analysis highlights the critical role of age, with older adults facing significantly higher risks of severe outcomes and death, particularly those with comorbidities. Racial and ethnic disparities are stark, with minority populations experiencing disproportionately higher mortality rates due to socioeconomic inequalities and limited access to healthcare. Socioeconomic status emerges as a pivotal determinant of COVID-19 outcomes, influencing mortality rates through factors such as crowded living conditions and limited healthcare access. Geographical differences further underscore the impact of local environmental and systemic factors on mortality rates, with variations observed between urban and rural areas as well as across different regions globally. The findings underscore the need for targeted public health interventions and policies to address these disparities and protect the most vulnerable populations.

Keywords: COVID-19 Mortality; Epidemiological Disparities; Demographic Variations; Racial Disparities; Socioeconomic Status; Comorbidities; Geographical Differences; Public Health Interventions

The COVID-19 pandemic has dramatically reshaped the global health landscape, claiming millions of lives and affecting every facet of society. Understanding the epidemiological and demographic variations in COVID-19 mortality is crucial for developing effective public health strategies and mitigating future pandemics. This paper aims to delve into the intricate patterns of COVID-19-related deaths, focusing on how various factors such as age, sex, race, socioeconomic status, and comorbidities have influenced mortality rates. Epidemiological data has consistently shown that certain demographic groups are disproportionately affected by COVID-19. For instance, studies have highlighted significant racial and ethnic disparities in COVID-19 outcomes, with minority populations experiencing higher mortality rates compared to their white counterparts [1,2]. Additionally, age and pre-existing health conditions have been identified as critical determinants of COVID-19 severity and mortality. Older adults and individuals with comorbidities such as cardiovascular disease, diabetes, and obesity are at a higher risk of severe outcomes [3,4].

Socioeconomic factors also play a pivotal role in shaping COVID-19 mortality rates. Research has indicated that lower socioeconomic status is associated with higher rates of infection and death due to a combination of factors, including limited access to healthcare, crowded living conditions, and higher exposure to the virus due to frontline and essential work roles [5,6]. Furthermore, healthcare infrastructure, such as the availability of medical resources and the quality of healthcare services, significantly influences mortality rates. Regions with robust healthcare systems have been better equipped to manage and treat COVID-19 patients, resulting in lower death rates [7,8]. This comprehensive analysis of COVID-19 mortality seeks to provide a deeper understanding of the epidemiological and demographic variations observed during the pandemic. By examining the intersection of these factors, this paper aims to contribute to the ongoing discourse on pandemic preparedness and response, highlighting the need for targeted interventions to protect the most vulnerable populations. The findings underscore the importance of addressing social determinants of health to reduce disparities and improve health outcomes during global health crises [9-13].

The COVID-19 pandemic has unveiled significant disparities in mortality rates influenced by a multitude of epidemiological and demographic factors. Analyzing these variations provides critical insights into the vulnerability of different population groups and informs public health interventions. This literature review synthesizes findings from recent studies to understand how factors such as age, comorbidities, socioeconomic status, race, and healthcare infrastructure contribute to the observed differences in COVID-19 mortality rates.

Numerous studies have consistently highlighted age as a crucial determinant of COVID-19 mortality. Older adults, particularly those above 60, exhibit higher mortality rates due to increased susceptibility to severe outcomes [14,15]. Comorbid conditions such as cardiovascular diseases, diabetes, and respiratory illnesses exacerbate this risk, leading to higher fatality rates among the elderly [16,17].

A systematic review confirmed that patients with multiple comorbidities are at a significantly higher risk of mortality [18]. Racial and ethnic disparities in COVID-19 outcomes have been starkly evident across various regions. Studies have shown that minority populations, particularly African American and Hispanic communities, face disproportionately higher mortality rates [19,20]. These disparities are attributed to a combination of factors including socioeconomic inequalities, limited access to healthcare, and higher prevalence of underlying health conditions [21,22]. The intersection of race and socioeconomic status further amplifies these vulnerabilities, underscoring the compounded disadvantage faced by these groups [23]. Socioeconomic status (SES) emerges as a pivotal factor influencing COVID-19 mortality. Lower SES is associated with higher exposure to the virus and limited access to healthcare resources, resulting in increased [24,25].

Ecological studies from Spain and other regions have demonstrated that areas with higher income inequality and lower public health expenditure have higher COVID-19 death rates [26,27]. This correlation emphasizes the need for equitable distribution of healthcare resources to mitigate the impact of pandemics on vulnerable populations [28]. Healthcare infrastructure also plays a critical role in determining COVID-19 mortality rates. Regions with well-equipped healthcare systems, including higher numbers of ICU beds and ventilators, have managed to reduce fatality rates [29,30]. Conversely, areas with overwhelmed healthcare systems experienced higher mortality, highlighting the importance of healthcare preparedness in pandemic response [31]. The variability in healthcare quality and accessibility across different regions underscores the disparities in health outcomes [32].

Geographical variations in COVID-19 mortality have also been observed, with certain latitudinal bands experiencing higher death rates. Studies have indicated that countries situated between the 25° and 65° northern parallels reported the highest mortality rates, possibly due to climatic factors, population density, and healthcare capacity [33,34]. This geographic pattern suggests that local environmental and systemic factors significantly influence pandemic outcomes [35]. The interplay of social determinants, healthcare infrastructure, and demographic factors creates a complex landscape influencing COVID-19 mortality rates. Addressing these disparities requires targeted public health interventions that consider the multifaceted nature of vulnerability [36,37]. By understanding and addressing the underlying causes of these disparities, policymakers can develop more effective strategies to protect the most at-risk populations during current and future public health crises [38,39].

COVID-19 has exhibited a distinctive pattern of mortality influenced by various epidemiological factors. The most significant among these is age, with older adults facing significantly higher risks of severe outcomes and death. Studies have consistently shown that mortality rates increase with age, particularly for those over 60 years old. According to Clark, et al. [3], the global estimates indicate that individuals aged 70 years and older have the highest mortality rates, which is exacerbated by underlying health conditions as illustrated in Figure 1. Comorbidities also play a critical role in COVID-19 mortality. Patients with pre-existing conditions such as cardiovascular disease, diabetes, chronic respiratory diseases, and hypertension are at a heightened risk of severe illness and death [4]. A systematic review by Petrilli, et al. [18] confirmed that the presence of multiple comorbidities significantly increases the likelihood of mortality among COVID-19 patients, as shown in Figure 1.

Figure 1

The impact of COVID-19 has not been uniform across different demographic groups, revealing stark disparities. Racial and ethnic minorities, particularly African American, Hispanic, and Native American communities, have experienced disproportionately higher mortality rates compared to their white counterparts. Tai, et al. [1] found that structural inequalities, including limited access to healthcare, higher prevalence of underlying health conditions, and socioeconomic disadvantages, contribute significantly to these disparities, as shown in Figure 2. Socioeconomic status (SES) is another crucial determinant of COVID-19 outcomes. Individuals with lower SES are more likely to experience severe outcomes and higher mortality rates due to factors such as crowded living conditions, limited access to healthcare, and employment in essential services that increase exposure to the virus [10]. In Figure 3, Mena et al. [4] demonstrated that regions with higher income inequality and lower public health expenditure saw higher COVID-19 mortality rates, emphasizing the need for equitable healthcare distribution.

Figure 2

Figure 3

Geographical location has also significantly influenced COVID-19 mortality rates, with notable differences observed between regions and countries. Countries situated between the 25° and 65° northern parallels reported the highest mortality rates, potentially due to a combination of climatic factors, population density, and healthcare capacity [36]. According to García-Basteiro, et al. [28], European countries such as Italy and Spain, as well as regions in the United States, experienced some of the highest mortality rates during the pandemic, as show in Figure 4. Urban versus rural differences also highlight geographical disparities in COVID-19 mortality. Urban areas, characterized by higher population density and greater mobility, saw higher infection and mortality rates compared to rural areas. This trend was evident in the United States, where major cities became epicenters of the outbreak. However, rural areas faced challenges such as limited healthcare infrastructure and delayed access to medical care, which also contributed to significant mortality rates shown in Figures 5 & 6 [34].

Figure 4

Figure 5

Figure 6

The COVID-19 pandemic has exposed and exacerbated existing disparities in health outcomes across different demographic and epidemiological groups. Our review demonstrates that age, comorbidities, race, socioeconomic status, and geographical location are significant determinants of COVID-19 mortality. Older adults and individuals with pre-existing health conditions face the highest risks, highlighting the need for prioritized healthcare resources and targeted protective measures. Racial and ethnic minorities, particularly African American and Hispanic communities, have experienced disproportionately higher mortality rates, underscoring the urgent need to address structural inequalities and improve access to healthcare. Socioeconomic status significantly influences COVID-19 outcomes, with lower-income individuals facing greater risks due to factors such as crowded living conditions and limited access to healthcare. Geographical differences in mortality rates point to the importance of robust healthcare infrastructure and tailored public health strategies for different regions. To effectively combat the disparities revealed by COVID-19, public health policies must prioritize equitable access to healthcare, targeted interventions for high-risk groups, and the strengthening of healthcare systems. Addressing the underlying social determinants of health and reducing socioeconomic and racial inequalities are essential steps in mitigating the impact of current and future pandemics. By understanding and addressing these disparities, policymakers can develop more effective strategies to protect vulnerable populations and improve health outcomes during global health crises.

1. Tai D B, Shah A, Doubeni C A, Sia I G, Wieland M L, et al. (2021) The disproportionate impact of COVID-19 on racial and ethnic minorities in the United States. Clinical Infectious Diseases 72(4): 703-706.
2. Price Haywood E G, Burton J, Fort D, Seoane L (2020) Hospitalization and mortality among black patients and white patients with Covid-19. New England Journal of Medicine 382(26): 2534-2543.
3. Clark A, Jit M, Warren Gash C, Guthrie B, Wang H H, et al. (2020) Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. The Lancet Global Health 8(8): e1003-e1017.
4. Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, et al. (2020) Comorbidity and its impact on patients with COVID-19. SN Comprehensive Clinical Medicine 2(8): 1069-1076.
5. Mena G E, Martinez P P, Mahmud A S, Marquet P A, Buckee C O, et al. (2021) Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile. Science 372(6545): eabg5298.
6. Adhikari S P, Meng S, Wu Y J, Mao Y P, Ye R X, et al. (2020) Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infectious Diseases of Poverty 9(1): 1-12.
7. Dasgupta S, Bowen V B, Leidner A, Fletcher K, Musial T, et al. (2021) Association between social vulnerability and a county’s risk for becoming a COVID-19 hotspot—United States, June 1–July 25, 2020. Morbidity and Mortality Weekly Report 70(11): 379.
8. Khazanchi R, Beiter E R, Gondi S, Beckman A L, Bilinski A, et al. (2020) County-level association of social vulnerability with COVID-19 cases and deaths in the USA. Journal of General Internal Medicine 35(9): 2784-2787.
9. Bambra C, Riordan R, Ford J, Matthews F (2020) The COVID-19 pandemic and health inequalities. Journal of Epidemiology and Community Health 74(11): 964-968.
10. Patel J A, Nielsen F B, Badiani A A, Assi S, Unadkat V A, et al. (2020) Poverty, inequality and COVID-19: the forgotten vulnerable. Public Health 183: 110.
11. Wadhera R K, Wadhera P, Gaba P, Figueroa J F, Joynt Maddox K E, et al. (2020) Variation in COVID-19 hospitalizations and deaths across New York City boroughs. JAMA 323(21): 2192-2195.
12. Yancy C W (2020) COVID-19 and African Americans. JAMA 323(19): 1891-1892.
13. Zhou F, Yu T, Du R, Fan G, Liu Y, et al. (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 395(10229): 1054-1062.
14. Bonanad Clara, Sergio García Blas, Francisco Tarazona Santabalbina, Juan Sanchis, Vicente Bertomeu Gonzále, et al. (2020) The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects. Journal of the American Medical Directors Association 21(7): 915-918.
15. Covino Marcello, Giuseppe De Matteis, Michele Santoro, Luca Sabia, Benedetta Simeoni, et al. (2020) Clinical characteristics and prognostic factors in COVID‐19 patients aged ≥ 80 years. Geriatrics & gerontology international 20(7): 704-708.
16. Guan W J, Ni Z Y, Hu Y, Liang W H, Ou C Q, et al. (2020) Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine 382(18): 1708-1720.
17. Péterfi Anna, Ágota Mészáros, Zsófia Szarvas, Melinda Pénzes, Mónika Fekete, et al. (2022) Comorbidities and increased mortality of COVID-19 among the elderly: A systematic review. Physiology international.
18. Petrilli C M, Jones S A, Yang J, Rajagopalan H, O Donnell L, et al. (2020) Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ, pp. 369.
19. Williamson E J, Walker A J, Bhaskaran K, Bacon S, Bates C, et al. (2020) Factors associated with COVID-19-related death using OpenSAFELY. Nature 584(7821): 430-436.
20. Mackey Katherine, Chelsea K Ayers, Karli K Kondo, Somnath Saha, Shailesh M Advani, et al. (2021) Racial and ethnic disparities in COVID-19–related infections, hospitalizations, and deaths: a systematic review. Annals of internal medicine 174.3: 362-373.
21. Millett G A, Jones A T, Benkeser D, Baral S, Mercer L, et al. (2020) Assessing differential impacts of COVID-19 on black communities. Annals of Epidemiology 47: 37-44.
22. Raifman M A, Raifman J R (2020) Disparities in the population at risk of severe illness from COVID-19 by race/ethnicity and income. American Journal of Preventive Medicine 59(1): 137-139.
23. Brown Tyson H, Liana J Richardson, Taylor W Hargrove, Courtney S Thomas (2016) Using multiple-hierarchy stratification and life course approaches to understand health inequalities: The intersecting consequences of race, gender, SES, and age. Journal of health and social behavior 57(2): 200-222.
24. Webb Hooper M, Nápoles A M, Pérez Stable E J (2020) COVID-19 and racial/ethnic disparities. JAMA 323(24): 2466-2467.
25. Consolazio David, Rossella Murtas, Sara Tunesi, Federico Gervasi, David Benassi, et al. (2021) Assessing the impact of individual characteristics and neighborhood socioeconomic status during the COVID-19 pandemic in the provinces of Milan and Lodi. International Journal of Health Services 51(3): 311-324.
26. Buja A, Paganini M, Cocchio S, Scioni M, Rebba V, et al. (2020) Demographic and socioeconomic factors, and healthcare resource indicators associated with the rapid spread of COVID-19 in Northern Italy: an ecological study. PLOS ONE 15(12): e0244535.
27. García Basteiro A L, Alvarez Dardet C, Arenas A, Bengoa R, Borrell C, et al. (2020) The need for an independent evaluation of the COVID-19 response in Spain. The Lancet 396(10250): 529-530.
28. Vieira Cristina Mesa, Oscar H Franco, Carlos Gómez Restrepo, Thomas Abel (2020) COVID-19: The forgotten priorities of the pandemic. Maturitas 136: 38-41.
29. Rodriguez Diaz C E, Guilamo Ramos V, Mena L, Hall E W, Honermann B, et al. (2020) Risk for COVID-19 infection and death among Latinos in the United States: examining heterogeneity in transmission dynamics. Annals of Epidemiology 52: 46-53.
30. Dasgupta S, Bowen V B, Leidner A, Fletcher K, Musial T, et al. (2021) Association between social vulnerability and a county’s risk for becoming a COVID-19 hotspot—United States, June 1–July 25, 2020. Morbidity and Mortality Weekly Report 70(11): 379.
31. Abel T, McQueen D (2020) The COVID-19 pandemic calls for spatial distancing and social closeness: not for social distancing!. International Journal of Public Health 65(3): 231-232.
32. Bader Mazen S, John Hawboldt, Annie Brooks (2010) Management of complicated urinary tract infections in the era of antimicrobial resistance. Postgraduate medicine 122(6): 7-15.
33. Neelon B, Mutiso F, Mueller N T, Pearce J L, Benjamin Neelon, et al. (2021) Spatial and temporal trends in social vulnerability and COVID-19 incidence and death rates in the United States. PLOS ONE 16(3): e0248702.
34. Gao Jianjun, Zhenxue Tian, Xu Yang (2020) Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Bioscience trends 14(1): 72-73.
35. Bontempi Elza, Sergio Vergalli, Flaminio Squazzoni (2020) Understanding COVID-19 diffusion requires an interdisciplinary, multi-dimensional approach. Environmental Research 188: 109814.
36. Marmot M, Allen J, Goldblatt P, Herd E, Morrison J, et al. (2020) Build back fairer: the COVID-19 Marmot review. BMJ, pp. 369.
37. Généreux M, Schluter P J, Hung K K, Wong C S, Pui Yin Mok C, et al. (2021) One virus, four continents, eight countries: an interdisciplinary and international study on the psychosocial impacts of the COVID-19 pandemic. International Journal of Environmental Research and Public Health 18(4): 1302.
38. Blundell R, Costa Dias M, Joyce R, Xu X (2020) COVID-19 and inequalities. Fiscal Studies 41(2): 291-319.
39. Alcendor Donald J (2020) Racial disparities-associated COVID-19 mortality among minority populations in the US. Journal of clinical medicine 9(8): 2442.